全文获取类型
收费全文 | 41121篇 |
免费 | 2899篇 |
国内免费 | 748篇 |
专业分类
耳鼻咽喉 | 212篇 |
儿科学 | 619篇 |
妇产科学 | 586篇 |
基础医学 | 3304篇 |
口腔科学 | 697篇 |
临床医学 | 5586篇 |
内科学 | 6668篇 |
皮肤病学 | 357篇 |
神经病学 | 2011篇 |
特种医学 | 1749篇 |
外国民族医学 | 291篇 |
外科学 | 3202篇 |
综合类 | 7243篇 |
现状与发展 | 4篇 |
预防医学 | 2700篇 |
眼科学 | 270篇 |
药学 | 4683篇 |
12篇 | |
中国医学 | 2390篇 |
肿瘤学 | 2184篇 |
出版年
2023年 | 405篇 |
2022年 | 515篇 |
2021年 | 1059篇 |
2020年 | 1109篇 |
2019年 | 1062篇 |
2018年 | 1181篇 |
2017年 | 944篇 |
2016年 | 895篇 |
2015年 | 910篇 |
2014年 | 5207篇 |
2013年 | 4294篇 |
2012年 | 3242篇 |
2011年 | 2980篇 |
2010年 | 4187篇 |
2009年 | 3922篇 |
2008年 | 2016篇 |
2007年 | 1135篇 |
2006年 | 892篇 |
2005年 | 817篇 |
2004年 | 694篇 |
2003年 | 626篇 |
2002年 | 521篇 |
2001年 | 510篇 |
2000年 | 448篇 |
1999年 | 405篇 |
1998年 | 377篇 |
1997年 | 338篇 |
1996年 | 311篇 |
1995年 | 337篇 |
1994年 | 323篇 |
1993年 | 278篇 |
1992年 | 260篇 |
1991年 | 236篇 |
1990年 | 235篇 |
1989年 | 205篇 |
1988年 | 221篇 |
1987年 | 168篇 |
1986年 | 153篇 |
1985年 | 216篇 |
1984年 | 207篇 |
1983年 | 150篇 |
1982年 | 181篇 |
1981年 | 132篇 |
1980年 | 91篇 |
1979年 | 71篇 |
1978年 | 62篇 |
1977年 | 53篇 |
1976年 | 52篇 |
1975年 | 24篇 |
1974年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
101.
《Diagnostic and interventional imaging》2020,101(12):821-830
PurposeTo compare morphological imaging features and CT texture histogram parameters between grade 3 pancreatic neuroendocrine tumors (G3-NET) and neuroendocrine carcinomas (NEC).Materials and methodsPatients with pathologically proven G3-NET and NEC, according to the 2017 World Health Organization classification who had CT and MRI examinations between 2006-2017 were retrospectively included. CT and MRI examinations were reviewed by two radiologists in consensus and analyzed with respect to tumor size, enhancement patterns, hemorrhagic content, liver metastases and lymphadenopathies. Texture histogram analysis of tumors was performed on arterial and portal phase CT images. images. Morphological imaging features and CT texture histogram parameters of G3-NETs and NECs were compared.ResultsThirty-seven patients (21 men, 16 women; mean age, 56 ± 13 [SD] years [range: 28-82 years]) with 37 tumors (mean diameter, 60 ± 46 [SD] mm) were included (CT available for all, MRI for 16/37, 43%). Twenty-three patients (23/37; 62%) had NEC and 14 patients (14/37; 38%) had G3-NET. NECs were larger than G3-NETs (mean, 70 ± 51 [SD] mm [range: 18 - 196 mm] vs. 42 ± 24 [SD] mm [range: 8 - 94 mm], respectively; P = 0.039), with more tumor necrosis (75% vs. 33%, respectively; P = 0.030) and lower attenuation on precontrast (30 ± 4 [SD] HU [range: 25-39 HU] vs. 37 ± 6 [SD] [range: 25-45 HU], respectively; P = 0.002) and on portal venous phase CT images (75 ± 18 [SD] HU [range: 43 - 108 HU] vs. 92 ± 19 [SD] HU [range: 46 - 117 HU], respectively; P = 0.014). Hemorrhagic content on MRI was only observed in NEC (P = 0.007). The mean ADC value was lower in NEC ([1.1 ± 0.1 (SD)] × 10−3 mm2/s [range: (0.91 - 1.3) × 10−3 mm2/s] vs. [1.4 ± 0.2 (SD)] × 10−3 mm2/s [range: (1.1 - 1.6) × 10−3 mm2/s]; P = 0.005). CT histogram analysis showed that NEC were more heterogeneous on portal venous phase images (Entropy-0: 4.7 ± 0.2 [SD] [range: 4.2-5.1] vs. 4.5 ± 0.4 [SD] [range: 3.7-4.9]; P = 0.023).ConclusionPancreatic NECs are larger, more frequently hypoattenuating and more heterogeneous with hemorrhagic content than G3-NET on CT and MRI. 相似文献
102.
《Journal of Cardiovascular Computed Tomography》2020,14(2):162-167
ObjectiveTo evaluate the feasibility of dual-energy CT (DECT)-based iodine quantification to estimate myocardial extracellular volume (ECV) fraction in patients with and without cardiomyopathy (CM), as well as to assess its ability to distinguish healthy myocardial tissue from cardiomyopathic, with the goal of defining a threshold ECV value for disease detection.MethodsTen subjects free of heart disease and 60 patients with CM (mean age 66.4 ± 9.4; 59 males and 11 females; 40 ischemic and 20 non-ischemic CM) underwent late iodine enhanced DECT imaging. Myocardial iodine maps were obtained using 3-material decomposition. ECV of the left ventricle was estimated from hematocrit levels and the iodine maps using the AHA 16-segment model. Receiver operating characteristic curve analysis was performed, with corresponding area under the curve, along with Youden's index assessment, to establish a threshold for CM detection.ResultsThe median ECV for healthy myocardium, non-ischemic CM, and ischemic CM were 25.4% (22.9–27.3), 38.3% (33.7–43.0), and 36.9% (32.4–41.1), respectively. Healthy myocardium showed significantly lower ECV values compared to ischemic and non-ischemic CM (p < 0.001). From Youden's index analysis, an ECV>29.5% would indicate the presence of CM in the myocardium (sensitivity = 90.3; specificity = 90.3); the AUC for this criterion was 0.950 (p < 0.001).ConclusionThe findings of this study resulted in a statistically significant distinction between healthy myocardium and CM ECVs. This led to the establishment of a promising threshold ECV value that could facilitate the differentiation between healthy and diseased myocardium, and highlights the potential of this DECT methodology to detect cardiomyopathic tissue. 相似文献
103.
104.
目的详细分析初次全血采集量不足原因。方法对2016-2018年焦作献全血情况进行调查,甄选出初次全血采集量不足者,细致探讨造成采集量不足的的原因。结果造成初次全血采集量不足原因,主要有7项,分别为精神因素、空腹献血、坐姿不当、采血者穿刺水平较低、个人因素、止血带以及环境因素。结论根据全血采集量不足原因制定一系列处理方案,可降低初次全血采集量不足的发生几率,能够更好地救治需要输血的患者。 相似文献
105.
106.
107.
108.
109.
Yao-Wen Chang Pei-Wen Hsieh Yu-Tsui Chang Meng-Hong Lu Tur-Fu Huang Kowit-Yu Chong Hsiang-Ruei Liao Ju-Chien Cheng Ching-Ping Tseng 《Oncotarget》2015,6(40):42733-42748
Podoplanin (PDPN) enhances tumor metastases by eliciting tumor cell-induced platelet aggregation (TCIPA) through activation of platelet C-type lectin-like receptor 2 (CLEC-2). A novel and non-cytotoxic 5-nitrobenzoate compound 2CP was synthesized that specifically inhibited the PDPN/CLEC-2 interaction and TCIPA with no effect on platelet aggregation stimulated by other platelet agonists. 2CP possessed anti-cancer metastatic activity in vivo and augmented the therapeutic efficacy of cisplatin in the experimental animal model without causing a bleeding risk. Analysis of the molecular action of 2CP further revealed that Akt1/PDK1 and PKCμ were two alternative CLEC-2 signaling pathways mediating PDPN-induced platelet activation. 2CP directly bound to CLEC-2 and, by competing with the same binding pocket of PDPN in CLEC-2, inhibited PDPN-mediated platelet activation. This study provides evidence that 2CP is the first defined platelet antagonist with CLEC-2 binding activity. The augmentation in the therapeutic efficacy of cisplatin by 2CP suggests that a combination of a chemotherapeutic agent and a drug with anti-TCIPA activity such as 2CP may prove clinically effective. 相似文献
110.